Benzinga

Benzinga

Benzinga

giovedì, settembre 03

Healthpeak Properties Inc

DOCNYSE
Trade with Public
Trade with Public
$21.03
N/A
In chiusura: Sep 3, 5:00 PM EST
$21.20
0.170.81%
Post-mercato: 4:48 PM EST
Dividendo: La data di stacco del dividendo è tra 11 giorni
PanoramicaNotiziePrevisioni utiliObiettivi di prezzoDati finanziariSentimentAzionariatoDividendiConfrontaOpzioniRapporto azionario

Healthpeak Properties Analyst Price Targets

Wall Street analyst price targets and consensus rating for Healthpeak Properties (DOC).

Price Target Range — 12 Quarters

Analyst Consensus — 19 Analysts

8Buy
11Hold
Consensus RatingOutperform# Analysts19Avg. Consensus PT$21Upside to Avg. PT+1.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 31, 2026BarclaysRichard HightowerPT RaiseEqual-Weight$23→$24
Aug 13, 2026BairdAmanda SweitzerPT RaiseOutperform$21→$24
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Barclays Maintains Equal-Weight on Healthpeak Properties, Raises Price Target to $24

Barclays analyst Richard Hightower maintains Healthpeak Properties (NYSE:DOC) with a Equal-Weight and raises the price target from $23 to $24.
Benzinga Newsdesk

Wall Street's Most Accurate Analysts Give Their Take On 3 Real Estate Stocks Delivering High-Dividend Yields

In uncertain markets, investors turn to dividend-yielding stocks. Benzinga provides latest analyst ratings & news for high-yielding stocks.
Avi Kapoor

PRO
Baird Maintains Outperform on Healthpeak Properties, Raises Price Target to $24

Baird analyst Amanda Sweitzer maintains Healthpeak Properties (NYSE:DOC) with a Outperform and raises the price target from $21 to $24.
Benzinga Newsdesk

PRO
Citigroup Maintains Neutral on Healthpeak Properties, Raises Price Target to $22

Citigroup analyst Nick Joseph maintains Healthpeak Properties (NYSE:DOC) with a Neutral and raises the price target from $20 to $22.
Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on Healthpeak Properties, Raises Price Target to $24

RBC Capital analyst Michael Carroll maintains Healthpeak Properties (NYSE:DOC) with a Outperform and raises the price target from $21 to $24.
Benzinga Newsdesk

PRO
Cantor Fitzgerald Maintains Neutral on Healthpeak Properties, Raises Price Target to $23

Cantor Fitzgerald analyst Richard Anderson maintains Healthpeak Properties (NYSE:DOC) with a Neutral and raises the price target from $20 to $23.
Benzinga Newsdesk

Dati e API: API Benzinga · API notizie azionarie · API valutazioni analisti · API logo aziende

Dati di mercato forniti da API Benzinga

Benzinga

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

© 2026 Benzinga | All Rights Reserved